Literature DB >> 18412346

Structure and dynamics of the Abeta(21-30) peptide from the interplay of NMR experiments and molecular simulations.

Nicolas L Fawzi1, Aaron H Phillips, Jory Z Ruscio, Michaeleen Doucleff, David E Wemmer, Teresa Head-Gordon.   

Abstract

We combine molecular dynamics simulations and new high-field NMR experiments to describe the solution structure of the Abeta(21-30) peptide fragment that may be relevant for understanding structural mechanisms related to Alzheimer's disease. By using two different empirical force-field combinations, we provide predictions of the three-bond scalar coupling constants ((3)J(H(N)H(alpha))), chemical-shift values, (13)C relaxation parameters, and rotating-frame nuclear Overhauser effect spectroscopy (ROESY) crosspeaks that can then be compared directly to the same observables measured in the corresponding NMR experiment of Abeta(21-30). We find robust prediction of the (13)C relaxation parameters and medium-range ROESY crosspeaks by using new generation TIP4P-Ew water and Amber ff99SB protein force fields, in which the NMR validates that the simulation yields both a structurally and dynamically correct ensemble over the entire Abeta(21-30) peptide. Analysis of the simulated ensemble shows that all medium-range ROE restraints are not satisfied simultaneously and demonstrates the structural diversity of the Abeta(21-30) conformations more completely than when determined from the experimental medium-range ROE restraints alone. We find that the structural ensemble of the Abeta(21-30) peptide involves a majority population (approximately 60%) of unstructured conformers, lacking any secondary structure or persistent hydrogen-bonding networks. However, the remaining minority population contains a substantial percentage of conformers with a beta-turn centered at Val24 and Gly25, as well as evidence of the Asp23 to Lys28 salt bridge important to the fibril structure. This study sets the stage for robust theoretical work on Abeta(1-40) and Abeta(1-42), for which collection of detailed NMR data on the monomer will be more challenging because of aggregation and fibril formation on experimental timescales at physiological conditions. In addition, we believe that the interplay of modern molecular simulation and high-quality NMR experiments has reached a fruitful stage for characterizing structural ensembles of disordered peptides and proteins in general.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412346      PMCID: PMC3474854          DOI: 10.1021/ja710366c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  65 in total

Review 1.  Unfolded state of peptides.

Authors:  Xavier Daura; Alice Glättli; Peter Gee; Christine Peter; Wilfred F van Gunsteren
Journal:  Adv Protein Chem       Date:  2002

2.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

3.  Structure of the 21-30 fragment of amyloid beta-protein.

Authors:  Andrij Baumketner; Summer L Bernstein; Thomas Wyttenbach; Noel D Lazo; David B Teplow; Michael T Bowers; Joan-Emma Shea
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

4.  Parametrisation of time-averaged distance restraints in MD simulations.

Authors:  A P Nanzer; W F van Gunsteren; A E Torda
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  Structure and dynamics of the homologous series of alanine peptides: a joint molecular dynamics/NMR study.

Authors:  Jürgen Graf; Phuong H Nguyen; Gerhard Stock; Harald Schwalbe
Journal:  J Am Chem Soc       Date:  2007-02-07       Impact factor: 15.419

6.  Improved structural characterizations of the drkN SH3 domain unfolded state suggest a compact ensemble with native-like and non-native structure.

Authors:  Joseph A Marsh; Chris Neale; Fernando E Jack; Wing-Yiu Choy; Anna Y Lee; Karin A Crowhurst; Julie D Forman-Kay
Journal:  J Mol Biol       Date:  2007-01-20       Impact factor: 5.469

7.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

8.  Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.

Authors:  H Sticht; P Bayer; D Willbold; S Dames; C Hilbich; K Beyreuther; R W Frank; P Rösch
Journal:  Eur J Biochem       Date:  1995-10-01

9.  'Random coil' 1H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG.

Authors:  G Merutka; H J Dyson; P E Wright
Journal:  J Biomol NMR       Date:  1995-01       Impact factor: 2.835

Review 10.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

View more
  65 in total

1.  Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.

Authors:  Yu-Shan Lin; Gregory R Bowman; Kyle A Beauchamp; Vijay S Pande
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

2.  Methods of NMR structure refinement: molecular dynamics simulations improve the agreement with measured NMR data of a C-terminal peptide of GCN4-p1.

Authors:  Jozica Dolenc; John H Missimer; Michel O Steinmetz; Wilfred F van Gunsteren
Journal:  J Biomol NMR       Date:  2010-06-04       Impact factor: 2.835

3.  Improved validation of IDP ensembles by one-bond Cα-Hα scalar couplings.

Authors:  Vytautas Gapsys; Raghavendran L Narayanan; ShengQi Xiang; Bert L de Groot; Markus Zweckstetter
Journal:  J Biomol NMR       Date:  2015-10-03       Impact factor: 2.835

4.  Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation.

Authors:  Hang Yu; Wei Han; Wen Ma; Klaus Schulten
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

Review 5.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

6.  Differences in β-strand populations of monomeric Aβ40 and Aβ42.

Authors:  K Aurelia Ball; Aaron H Phillips; David E Wemmer; Teresa Head-Gordon
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

7.  Using a reduced dimensionality model to compute the thermodynamic properties of finite polypeptide aggregates.

Authors:  Gustavo E López; Anthony Cruz; Melyorise Sepulveda-Chervony; Juan López-Garriga; Madeline Torres-Lugo
Journal:  J Biol Phys       Date:  2012-02-02       Impact factor: 1.365

8.  Evaluating the performance of the ff99SB force field based on NMR scalar coupling data.

Authors:  Lauren Wickstrom; Asim Okur; Carlos Simmerling
Journal:  Biophys J       Date:  2009-08-05       Impact factor: 4.033

9.  Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.

Authors:  Mary Griffin Krone; Andrij Baumketner; Summer L Bernstein; Thomas Wyttenbach; Noel D Lazo; David B Teplow; Michael T Bowers; Joan-Emma Shea
Journal:  J Mol Biol       Date:  2008-06-04       Impact factor: 5.469

10.  Biophysical characterization of Abeta42 C-terminal fragments: inhibitors of Abeta42 neurotoxicity.

Authors:  Huiyuan Li; Bernhard H Monien; Erica A Fradinger; Brigita Urbanc; Gal Bitan
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.